NM_000157.4:c.38A>G
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_000157.4(GBA1):c.38A>G(p.Lys13Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00417 in 1,613,436 control chromosomes in the GnomAD database, including 222 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000157.4 missense
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Gaucher diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Gaucher disease perinatal lethalInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Gaucher disease type IInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Gaucher disease type IIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Gaucher disease type IIIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GBA1 | NM_000157.4 | c.38A>G | p.Lys13Arg | missense_variant | Exon 2 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0222 AC: 3374AN: 152110Hom.: 117 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00565 AC: 1418AN: 250914 AF XY: 0.00395 show subpopulations
GnomAD4 exome AF: 0.00230 AC: 3354AN: 1461208Hom.: 104 Cov.: 31 AF XY: 0.00191 AC XY: 1385AN XY: 726942 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0222 AC: 3382AN: 152228Hom.: 118 Cov.: 32 AF XY: 0.0204 AC XY: 1517AN XY: 74418 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
This variant is associated with the following publications: (PMID: 32658388, 30302829, 26117366, 26296077, 28030538, 27884173, 17059888, 25525159, 22001711, 23588557) -
- -
- -
- -
not specified Benign:2
- -
- -
Gaucher disease type I Pathogenic:1
This is the only variant detected at the GBA locus in this allele in compound heterozigosity (in trans) with a previously described variant of Gaucher disease - genotype N409S/W223R/K13R. Mutation detected and described in Gaucher disease patients (n=1) in Rozenberg et al., 2006 (doi:10.1016/j.bcmd.2006.09.004), in dementia with Lewy bodies patients (n=1), and in Parkinson's disease patients (n=8) in Siebert et al., 2012 (doi:10.1016/j.parkreldis.2011.09.024), Mata et al., 2015 (doi:10.1002/mds.26359), and Petrucci et al., 2020 (doi: 10.1002/mds.28195). Based on these data and established disease mechanisms for GBA1, we classified it as likely pathogenic. -
Gaucher disease Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at